Nominee pool grows for stem-cell czar
By San Francisco Chronicle,
San Francisco Chronicle
| 12. 12. 2004
Some of the architects assembling California's $3 billion stem cell project are pushing for a competitive process to select a chairman to lead the experiment, rather than automatically backing the man considered to be the likely candidate for the job.
Robert Klein, the Palo Alto real estate developer, is regarded as the leading contender for the job in part because the peculiar language of the proposition seemed closely tailored to someone with his background. He said last week he would be willing to serve, at least for a while, before he returns to his business ventures.
State officials technically had until today to appoint policy makers to run the California Institute for Regenerative Medicine, which voters created Nov. 2 by passing Proposition 71. As of Friday, only 13 of 29 members had been named to the institute's governing body, known as the Independent Citizens Oversight Committee.
Twenty-seven members will be appointed by various state officials. The last two are supposed to be nominated to the posts of chair and vice chair by four particular state officials -- the governor, lieutenant...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...